SMi’s 5th Annual 3D Cell Culture Conference
Event Feb 10 - Feb 11, 2021
Online Access Only
3D Cell Culture is gaining momentum in the pharmaceutical industry, with the global 3D Cell Culture market predicted to surpass a value of $3.2 Billion by 2027. Researchers globally are realising the potential of in vitro applications for drug discovery, predictivity and validation, safety, and toxicity.
SMi’s 5th Annual 3D Cell Culture Conference will be covering the application of 3D cell culture to drug development, toxicity testing, and safety assurance. In addition, the conference will look into the newest breakthroughs in Organ Chip technology, 3D Multicellular scaffolding, micro-physiological Systems, and 3D Bioprinting. In recent years technological advances have made these technologies viable and accessible in scientific application.
Event Hashtag: #SMi3DCellCulture
HIGHLIGHTS FOR 2021
•Discover the cutting-edge technology that is changing the face of pharmaceutical drug development
•Explore the necessity of utilising 3D models in the cytotoxic testing of biologics over traditional alternatives
•Insight into the capacity for micro-physiological systems and organ-on-a-chip technology to mimic cellular microenvironments in vitro
•Discuss current case studies in applied 3D cell models that are changing the future of pharmaceutical drug discovery
•Assess the biophysiological competency of MPS and 3D Bioprinting at the pre-conference workshops